N4 Pharma PLC (N4P)

London
7.800
-0.150(-1.89%)
  • Volume:
    549,434
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    7.800 - 7.800

N4P Overview

Prev. Close
7.95
Day's Range
7.8-7.8
Revenue
-
Open
7.95
52 wk Range
5-14.5
EPS
-0.01
Volume
549,434
Market Cap
14.12M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
936,802
P/E Ratio
-
Beta
-1.51
1-Year Change
27.87%
Shares Outstanding
181,080,349
Next Earnings Date
-
What is your sentiment on N4 Pharma PLC?
or
Market is currently closed. Voting is open during market hours.

N4 Pharma PLC News

  • N4 Pharma falls after update
    • ByProactiveinvestors-

    10.13am: Vaccine specialist reports increased losses N4 Pharma PLC (LON.N4P) has dropped sharply after reporting increased losses for the year. The company, which is developing a...

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellNeutral

N4 Pharma PLC Company Profile

N4 Pharma PLC Company Profile

Employees
4

N4 Pharma Plc, formerly Onzima Ventures plc, is a United Kingdom-based specialist pharmaceutical company. The Company is engaged in reformulating existing drugs and vaccines to improve their performance. It operates in two divisions: generic and vaccines. Its generics division includes Sildenafil, Sartans, Aprepitant and Single dose Hepatitis B. Its vaccines include Nuvac and Nuvec. The Company is improving Sildenafil for erectile dysfunction. Sartans is a family of drugs known as Angiotensin II antagonists, including Losartan and Valsartan, commonly used for the treatment of hypertension. Aprepitant is an anti-emetic drug used in oncology. It is reformulating the existing Hepatitis B surface antigen vaccine (HBsAg), a sub unit vaccine. Nuvac is a nano-carrier delivery system for vaccines. Nuvec is an engineered silica nanoparticle, which has been designed for the intracellular delivery of large nucleic acids such as plasmid deoxyribonucleic acid and messenger ribonucleic acid.

Read More
  • 20p today!
    3
    • Next stop 29p!
      3
      • Is it a good time to get in or not worth touching?
        0
        • second dump stage now
          0
          • what a suprise, finally falls on hype bubble and no assets to fall on🤣
            0
            • Get rid of sellers , then gone fly over 20🚀💰
              0
              • Bought some as a long-term investment. Looks promising in my opinion
                0
                • Im investing in this on monday unless someone can give me a reason not to thats valid
                  0
                  • low 8's for a bounce
                    3
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.